720 related articles for article (PubMed ID: 11520320)
21. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes.
Bélanger S; Coulombe G; Carmant L
Epilepsia; 1998 Aug; 39(8):878-83. PubMed ID: 9701380
[TBL] [Abstract][Full Text] [Related]
22. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs.
White HS
Epilepsia; 1999; 40 Suppl 5():S2-10. PubMed ID: 10530688
[TBL] [Abstract][Full Text] [Related]
23. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs.
White HS
Epilepsia; 1997; 38 Suppl 1():S9-17. PubMed ID: 9092952
[TBL] [Abstract][Full Text] [Related]
25. Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study.
Zeng QY; Fan TT; Zhu P; He RQ; Bao YX; Zheng RY; Xu HQ
PLoS One; 2015; 10(7):e0131566. PubMed ID: 26147937
[TBL] [Abstract][Full Text] [Related]
26. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies.
Nicolson A; Appleton RE; Chadwick DW; Smith DF
J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):75-9. PubMed ID: 14707312
[TBL] [Abstract][Full Text] [Related]
27. Pharmacotherapy for tonic-clonic seizures.
Rheims S; Ryvlin P
Expert Opin Pharmacother; 2014 Jul; 15(10):1417-26. PubMed ID: 24798217
[TBL] [Abstract][Full Text] [Related]
28. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
Moeller JJ; Rahey SR; Sadler RM
Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
[TBL] [Abstract][Full Text] [Related]
29. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
Montouris G; Abou-Khalil B
Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
[TBL] [Abstract][Full Text] [Related]
30. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
Marson AG; Al-Kharusi AM; Alwaidh M; Appleton R; Baker GA; Chadwick DW; Cramp C; Cockerell OC; Cooper PN; Doughty J; Eaton B; Gamble C; Goulding PJ; Howell SJ; Hughes A; Jackson M; Jacoby A; Kellett M; Lawson GR; Leach JP; Nicolaides P; Roberts R; Shackley P; Shen J; Smith DF; Smith PE; Smith CT; Vanoli A; Williamson PR;
Lancet; 2007 Mar; 369(9566):1016-26. PubMed ID: 17382828
[TBL] [Abstract][Full Text] [Related]
31. [Antiepileptic drugs in North America].
Akiyama T; Otsubo H
Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099
[TBL] [Abstract][Full Text] [Related]
32. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
[TBL] [Abstract][Full Text] [Related]
33. Lamotrigine in absence and primary generalized epilepsies.
Mikati MA; Holmes GL
J Child Neurol; 1997 Nov; 12 Suppl 1():S29-37. PubMed ID: 9429128
[TBL] [Abstract][Full Text] [Related]
34. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
Steinhoff BJ; Ueberall MA; Siemes H; Kurlemann G; Schmitz B; Bergmann L;
Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
Epilepsia; 2004 May; 45(5):401-9. PubMed ID: 15101821
[TBL] [Abstract][Full Text] [Related]
36. Treatment of epilepsy in adults: expert opinion, 2005.
Karceski S; Morrell MJ; Carpenter D
Epilepsy Behav; 2005 Sep; 7 Suppl 1():S1-64; quiz S65-7. PubMed ID: 16102515
[TBL] [Abstract][Full Text] [Related]
37. [Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic frontal lobe epilepsy in children].
Boldyreva SR; Ermakov AIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):58-65. PubMed ID: 20559276
[TBL] [Abstract][Full Text] [Related]
38. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses.
Campos MSA; Ayres LR; Morelo MRS; Carizio FAM; Pereira LRL
Int J Clin Pharm; 2018 Jun; 40(3):589-598. PubMed ID: 29744790
[TBL] [Abstract][Full Text] [Related]
39. Lamotrigine versus carbamazepine monotherapy for epilepsy.
Gamble CL; Williamson PR; Marson AG
Cochrane Database Syst Rev; 2006 Jan; (1):CD001031. PubMed ID: 16437428
[TBL] [Abstract][Full Text] [Related]
40. The new antiepileptic drugs: a systematic review of their efficacy and tolerability.
Marson AG; Kadir ZA; Hutton JL; Chadwick DW
Epilepsia; 1997 Aug; 38(8):859-80. PubMed ID: 9579887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
